- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04462289
Electronic Proactive Outreach for Smokers With COPD
Electronic Proactive Outreach for Smokers With COPD: Engaging Patients to Quit (CDA 19-081)
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases, with 90% of cases directly attributable to smoking. Unfortunately, many patients continue to smoke and have an urgent need to quit. Proactive tobacco treatment programs identify patients outside of a routine clinical appointment and engage them in making a supported quit attempt.
Most previous research of proactive tobacco treatment has used telephone outreach, which can be resource intensive. Electronic methods (texting, secure messaging) may be effective while requiring fewer resources.
In this study, a previously tested telephone outreach intervention will be adapted for electronic delivery, with content tailored to smokers with COPD. First, information will be gathered from smokers with COPD and the medical staff who care for them to adapt the program for electronic delivery. Then, the program will be pilot-tested. Smokers with COPD will be randomly assigned to either usual medical care or the outreach intervention, with goals to increase participation in smoking cessation programs, quit attempts, and successful cessation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory conditions and the 4th leading cause of death in the US. 90% of cases are directly attributable to smoking. Quitting smoking is the most important intervention for these patients, who continue to smoke at rates double the national average. Smokers with COPD remain undertreated for tobacco use. Proactive tobacco treatment programs identify patients outside of a routine clinic visit, engage them in making a quit attempt and connect them with treatment. These programs may be particularly beneficial for smokers with COPD. Previous phone-based programs are resource intensive to deliver. Electronic methods for delivering proactive outreach for tobacco cessation may be effective and cost-effective, and can be tailored to the target population.
Hypothesis: A proactive tobacco treatment program adapted to electronic delivery and tailored to smokers with COPD will be effective and cost effective for increasing quit engagement among smokers with COPD.
Study design: Multi-aim implementation study with randomized pilot. Aim 1: Mixed methods (survey and interview) assessment of current use of health information technology among smokers with COPD with a focus on the impact of the chronic disease state on tobacco cessation.
Aim 2: Qualitative assessment of barriers and facilitators to implementation of proactive tobacco treatment programs for patients with COPD among staff and leadership.
Aim 3: Randomized pilot of a proactive tobacco treatment program for smokers with COPD delivered through phone and text messaging.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55417-2309
- Minneapolis VA Health Care System, Minneapolis, MN
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Veterans active in clinical care (at least one primary care or pulmonary visit within the past year)
- Past-year smoking status in the electronic health record indicating current smoking, confirmed on enrollment call
- Diagnosed with COPD (2 ICD-10 diagnoses of COPD within the past 2 years)
- Currently enrolled in MyHealtheVet secure messaging
Exclusion Criteria:
- Already enrolled in behavioral VA tobacco treatment
- Enrolled in hospice
- Undergoing active cancer treatment
- Advanced dementia
- Unable to communicate in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
Randomly assigned sample who will receive usual care for tobacco cessation treatment
|
|
Experimental: Proactive Outreach
Randomly assigned sample who will receive a proactive offer of tobacco treatment with connection to motivational texting program.
|
Motivational electronic offer of tobacco cessation support via motivational texting program with care connection to patient's choice of smoking cessation programs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response to outreach intervention
Time Frame: 60 days
|
Proportion of participants who respond to the proactive offer, feasibility outcome
|
60 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participation in tobacco cessation treatment
Time Frame: 6 months
|
Any participation in tobacco cessation treatment (medication use, counseling)
|
6 months
|
Rate of Smoking cessation
Time Frame: 6 months
|
Self-reported and biochemically confirmed smoking cessation
|
6 months
|
Number of Quit attempts
Time Frame: 6 months
|
Self-reported attempts to quit smoking
|
6 months
|
Marginal Cost
Time Frame: 6 months
|
Cost associated with the proactive program, encompassing both direct costs and indirect costs related to increased use of quit resources and medications
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anne C. Melzer, MD MS, Minneapolis VA Health Care System, Minneapolis, MN
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDX 20-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Proactive Outreach
-
Harvard Medical School (HMS and HSDM)Humana Co.Ltd.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Massachusetts General HospitalNot yet recruitingFood Insecurity | Nutrition, Healthy | Vulnerable Populations
-
NYU Langone HealthEnrolling by invitation
-
Kaiser PermanenteUniversity of MichiganCompleted
-
NYU Langone HealthNational Cancer Institute (NCI)Completed
-
US Department of Veterans AffairsUniversity of California, San Diego; California Smokers' HelplineCompleted
-
VA Office of Research and DevelopmentCompleted
-
Medical University of South CarolinaNational Cancer Institute (NCI)RecruitingHiv | Smoking, CigaretteUnited States
-
University of MinnesotaRecruitingCardiovascular Diseases | Smoking | Smoking Cessation | Tobacco Use | Tobacco Use CessationUnited States
-
US Department of Veterans AffairsCompleted